Huawei and Xiehe jointly developed a patent for non-invasive diabetes testing to solve the risk of inaccurate testing results

Huawei Technologies Co., Ltd. and Peking Union Medical College Hospital of the Chinese Academy of Medical Sciences recently announced a patent titled "Diabetes Risk Detection Method, Electronic Device and System." This patent is expected to provide a more accurate and convenient method for detecting diabetes and further promote the development of medical technology.

The abstract shows that this patent is applied in the field of terminal technology,to solve the problem of short PPG signal collection time in the existing technology. , the problem of inaccurate diabetes risk test results.

Note on this website: PPG refers to photo plethysmo graphic, photoplethysmography.

The method includes: obtaining the first data and the second data. The first data is a PPG signal obtained by a photoplethysmography (PPG) sensor. The second data may include one or more of the following: diet data, exercise data, physical symptom data, drug usage data, sleep data, and emotion data.

This embodiment is used to determine the diabetes risk based on the first and second data, and output the detection results to prompt the user's health status. It is suitable for use in non-invasive diabetes risk testing procedures.

The patent summary diagram shows that the patent not only supports non-invasive detection of diabetes, can also provide users with health advice, such as maintaining a low-sugar and low-fat diet, increasing exercise appropriately, etc.

The above is the detailed content of Huawei and Xiehe jointly developed a patent for non-invasive diabetes testing to solve the risk of inaccurate testing results. For more information, please follow other related articles on the PHP Chinese website!